| P.1 Molecular neuropsychopharmacology |
| |
|
| P.1.002 |
(PDF 269 kb) |
| Role of 5-HT2A-receptor and a2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow |
 Olivia Frånberg, Sweden |
| |
|
| P.1.003 |
(PDF 346 kb) |
| Brain-derived neurotrophic factor as a biomarker of clinical response in bipolar disorder: 16-week follow-up study |
| Iria Grande, Spain |
| |
|
| P.1.004 |
(PDF 243 kb) |
| Lower BDNF levels in schizophrenia than in control population: a case-control study |
| Alicia Valiente, Spain |
| |
|
| P.1.006 |
(PDF 340 kb) |
| Stimulation of D3 receptors activates Akt/GSK-3beta and mTOR signalling pathways in nucleus accumbens and striatum |
| Marie-Josèphe Salles, France |
| |
|
| P.1.007 |
(PDF 150 kb) |
| Time-course analysis of hormonal and neuroplastic changes in rats exposed to prenatal stress |
| Alessia Luoni, Italy |
| |
|
| P.1.009 |
(PDF 4,33 mb) |
| Increased mRNA expression and release of neuropeptide S after REM sleep deprivation in rat. |
| Csaba Adori, Sweden |
| |
|
| P.1.011 |
(PDF 530 kb) |
| Identifying transcriptomic biomarkers for response to escitalopram in the inflammatory cytokine pathway |
| Timothy Powell, United Kingdom |
| |
|
| P.1.012 |
(PDF 728 kb) |
| Protein kinase C inhibition rescues manic-like behaviour and impairment of hippocampal cell proliferation induced by sleep deprivation |
| Erika Abrial, France |
| |
|
| P.1.013 |
(PDF 873 kb) |
| Variants in catechol-o-methyltransferase gene are associated with impulsivity and executive function: relevance for major depression |
| Dorottya Pap, Hungary |
| |
|
| P.1.014 |
(PDF 187 kb) |
| Spatial memory and expression levels of BDNF and steroid hormone receptors in the hippocampus of social isolated offspring |
| Pierluigi Olla, Italy |
| |
|
| P.1.015 |
(PDF 405 kb) |
| Selective methylation of brain derived neurotrophic factor gene promoter in bipolar disorder: differences between patients and controls |
| Beatrice Benatti, Italy |
| |
|
| P.1.016 |
(PDF 338 kb) |
| The role of nitric oxide signalling in impulsive behaviours |
| Aet Alttoa, Germany |
| |
|
| P.1.017 |
(PDF 182 kb) |
| Stress-induced enhancement of synaptic plasticity in the amygdala of mice depends on both glucocorticoid and ß-adrenergic activity |
| Ratna Angela Sarabdjitsingh, The Netherlands |
| |
|
| P.1.019 |
(PDF 811 kb) |
| Does the progranulin gene variability decrease the risk to develop bipolar disorder and schizophrenia? |
| M.Carlotta Palazzo, Italy |
| |
|
| P.1.021 |
(PDF 792 kb) |
| Longitudinal changes of n-acetyl-aspartate in early onset psychosis |
| Marta Rapado-Castro, Spain |
| |
|
| P.1.025 |
(PDF 638 kb) |
| Restoration of oscillatory changes in the genetic NMDA receptor hypofunction mutant PV-Cre/NR1f/f, |
| Xinming Wang, Sweden |
| |
|
| P.1.026 |
(PDF 1,49 mb) |
| Sub-chronic phencyclidine alters GABAergic gene expression in rat frontal cortex: focus on tonic inhibition and its relevance to cognition |
| James Glasper, United Kingdom |
| |
|
| P.1.030 |
(PDF 652 kb) |
| Antagonist dissociation from dopamine D2 receptors: studies using a time-resolved ion channel activation assay |
| Kristoffer Sahlholm, Sweden |
| |
|
| P.2 Behavioural pharmacology |
| |
|
| P.2.001 |
(PDF 385 kb) |
| Differential effects of central oxytocin on social versus cued fear |
| Iulia Toth, Germany |
| |
|
| P.2.002 |
(PDF 74 kb) |
| Positive allosteric modulation of metabotropic glutamate 5 receptors prevents and reverses social discrimination deficits in rats |
| Nadège Morisot, France |
| |
|
| P.2.003 |
(PDF 1,07 mb) |
| Inhibition of the phosphatidylinositol-3 kinase cascade in corticolimbic structures: possible target to erase fear memories |
| Milly Kritman, Israel |
| |
|
| P.2.006 |
(PDF 1,02 mb) |
| Ontogeny of cognitive impairment following prenatal infection |
| Juliet Richetto, Italy |
| |
|
| P.2.008 |
(PDF 1 mb) |
| Neurobiological correlates of cocaine-induced anxiety in withdrawn rats |
| Cynthia El Hage, France |
| |
|
| P.2.009 |
(PDF 650 kb) |
| The effect of acutely induced anxiety in a successive negative contrast task in humans |
| Michael Anderson, United Kingdom |
| |
|
| P.2.010 |
(PDF 450 kb) |
| Carbon dioxide-induced anxiety and the successive negative contrast effect in rats |
| Emma Mitchell, United Kingdom |
| |
|
| P.2.011 |
(PDF 2,19 mb) |
| Decreased levels of allopregnanolone induced by oral contraceptives is associated with a reduction in social behaviour and sexual motivation in rats |
| Roberta Berretti, Italy |
| |
|
| P.2.012 |
(PDF 925 kb) |
| Long-lasting memory abnormalities following exposure to the mouse defense test battery |
| Julie Philbert, France |
| |
|
| P.2.013 |
(PDF 823 kb) |
| Effects of melatonin on diurnal variations of spontaneous seizures and behavioural changes in kainate model of temporal lobe epilepsy |
| Zlatina Petkova, Bulgaria |
| |
|
| P.2.014 |
(PDF 1,46 mb) |
| Potentiation of donepezil efficiency profile by connexins inhibitors in aged related cognitive impairment |
| Matthias Vandesquille, France |
| |
|
| P.2.015 |
(PDF 295 kb) |
| An anxiolytic but not antidepressant-like activity of a novel positive modulator of mGlu4 receptor Lu AF21394 |
| Anna Slawinska, Poland |
| |
|
| P.2.016 |
(PDF 1,02 mb) |
| Changes in basal and fluoxetine-induced adult neurogenesis and depression-related behaviours in transgenic S100B over-expressing mice |
| Vasco Sousa, Sweden |
| |
|
| P.2.018 |
(PDF 790 kb) |
| Antidepressants specifically inhibiting noradrenaline reuptake enhance recognition memory in rats |
| Kristin Feltmann, Sweden |
| |
|
| P.2.019 |
(PDF 141 kb) |
| BDNF/TrkB signaling in learning and memory: the effects of 7,8-dihydroxyflavone on object memory |
| Eva Bollen, The Netherlands |
| |
|
| P.2.020 |
(PDF 1,20 mb) |
| Housing conditions affect memory performance and drug efficacy in the rat |
| Sven Akkerman, The Netherlands |
| |
|
| |
|
| P.3 Clinical neuropsychopharmacology |
| |
|
| P.3.003 |
(PDF 785 kb) |
| The need for antidepressants in chronic haemodialysis |
| Costin Roventa, Romania |
| |
|
| P.3.004 |
(PDF 1,79 mb) |
| Amphetamine-opioid interactions in the human brain reward system - a PET study using [11C]carfentanil |
| Joar Guterstam, Sweden |
| |
|
| P.3.005 |
(PDF 1,05 mb) |
| Tardive dyskinesia and polymorphism of phosphatidylinositol- 4-phosphate 5-kinase IIa gene in Russian schizophrenic patients |
| Valentina Gavrilova, Russia |
| |
|
| P.3.006 |
(PDF 2,15 mb) |
| Effect of psychiatric co-morbidity and the method of insulin therapy on metabolic control in children with type 1 diabetes |
| Agnieszka Butwicka, Poland |
| |
|
| P.3.008 |
(PDF 709 kb) |
| SLC2A3: a new candidate gene for attention-deficit/hyperactivity disorder |
| Sören Merker, Germany |
| |
|
| P.3.010 |
(PDF 670 kb) |
| Genetic variability at IMPA-2, INNP-1 and glycogen synthase kinase (GSK)-3ß increases the risk of suicidal behaviour in bipolar patients |
| Esther Jimenez, Spain |
| |
|
| P.3.011 |
(PDF 1,56 mb) |
| Risk factors for suicidal ideation among HIV-infected drinkers in Russia |
| Tatiana Yaroslavtseva, Russia |
| |
|
| P.3.012 |
(PDF 1,34 mb) |
| Effectiveness of naltrexone in the double blind placebo controlled clinical trial of naltrexone and guanfacine for heroin dependence |
| Vladimir Palatkin, Russia |
| |
|
| P.3.013 |
(PDF 4,08 mb) |
| Neurocognitive impairment in euthymic bipolar disorder: a functional magnetic resonance imaging study with a working memory task |
| Laura Cremaschi, Italy |
| |
|
| P.3.015 |
(PDF 1 mb) |
| Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677c->t polymorphism and psychiatric disorders in children |
| Laura Kevere, Latvia |
| |
|
| P.3.016 |
(PDF 98 kb) |
| Oxcarbazepine, topiramate and lamotrigine in treatment of alcohol craving |
| Bojana Bajovic, Serbia |
| |
|
| P.3.019 |
(PDF 756 kb) |
| Impact of lithium on oxidative stress parameters in human plasma in vitro and neuroblastoma SH-SY5Y oxidative stress level and viability |
| Oliwia Gawlik, Poland |
| |
|
| P.3.020 |
(PDF 480 kb) |
| The role of P-glycoprotein in central antihistamine effects |
| Silke Conen, The Netherlands |
| |
|
| P.3.021 |
(PDF 5,14 mb) |
| Potential benefits of slow titration of paroxetine treatment in elderly population: 6-month results from a naturalistic setting |
| Sara Gibiino, Italy |
| |
|
| P.3.023 |
(PDF 1,10 mb) |
| Metabolic risk after six months of treatment with second-generation antipsychotics in antipsychotic-naïve children and adolescents |
| Covadonga M. Díaz-Caneja, Spain |
| |
|
| P.3.024 |
(PDF 614 kb) |
| Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonist |
| Maartje Luijten, The Netherlands |
| |
|
| P.3.026 |
(PDF 728 kb) |
| Clinical and genetic predictors of antidepressant response and remission in treatment resistant depression |
| Raffaella Calati, Italy |
| |
|
| P.3.027 |
(PDF 256 kb) |
| A single dose of the antidepressant fluoxetine modulates emotional processing in young adult volunteers |
| Liliana Capitao, United Kingdom |
| |
|
| P.3.028 |
(PDF 389 kb) |
| Antenatal depression and infant sleep 6 months postpartum: examining the moderating effects of the 5-HTTLPR and temperament |
| Elena Netsi, United Kingdom |
| |
|
| P.3.029 |
(PDF 222 kb) |
| Chronic cannabis use and dopamine synthesis capacity: an [18F]-DOPA positron emission tomography study |
| Michael Bloomfield, United Kingdom |
| |
|
| P.3.032 |
(PDF 515 kb) |
| Acute mediofrontal and insular brain hypoperfusion after heroin administration in addicts: a within subject arterial spin labeling study |
| Niklaus Denier, Switzerland |
| |
|
| |
|
| P.4 Depression: towards new drug targets |
| |
|
| P.4.003 |
(PDF 223 kb) |
| A neural cell adhesion molecule (NCAM)-derived peptide, FGL, counteracts serotonergic dysfunction in NCAM-deficient mice |
| Anu Aonurm-Helm, Estonia |
| |
|
| P.4.005 |
(PDF 118 kb) |
| Effect of antidepressant drugs on dopamine D2 and somatostatin Sst5 receptors heterodimerisation - fluorescence in vitro studies |
| Kinga Szafran, Poland |
| |
|
| P.4.008 |
(PDF 4,64 mb) |
| Larger grey matter volume reductions are related to longer duration of major depressive disorder |
| Maria Serra, Spain |
| |
|
| P.4.014 |
(PDF 1,06 mb) |
| Deep brain stimulation in treatment-resistant depression in mice |
| Carine Dournes, France |
| |
|
| P.4.015 |
(PDF 80 kb) |
| Gene expression profile associated with major depression and with antidepressant response |
| Annamaria Cattaneo, Italy |
| |
|
| P.4.016 |
(PDF 369 kb) |
| GABAB(1) receptor subunit isoforms differentially mediate susceptibility to depression-related behaviour following early-life stress |
| Daniela Felice, Ireland |
| |
|
| P.4.017 |
(PDF 1,34 mb) |
| Cortisol decreases hippocampal neurogenesis by regulating the enzyme serum- and glucocorticoid-regulated kinase 1 |
| Christoph Anacker, United Kingdom |
| |
|
| P.4.018 |
(PDF 184 kb) |
| The effect of acute imipramine on amphetamine-induced striatal dopamine and serotonin release in low and high exploring rats |
| Kadri Koiv, Estonia |
| |
|
| P.4.019 |
(PDF 945 kb) |
| Targeting cognitive impairment in anxiety disorders: transcriptional actions of glucocorticoid receptor modulators |
| Chinedu Udeh, United Kingdom |
| |
|
| P.4.020 |
(PDF 861 kb) |
| Fluoxetine acts not only as an antidepressant: inhibitory effect on murine melanoma growth |
| Beata Grygier, Poland |
| |
|
| P.4.022 |
(PDF 1,38 mb) |
| Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants |
| Mariagrazia Pelizzari, Italy |
| |
|
